Lymphokine SAF and method of making
Number of patents in Portfolio can not be more than 2000
United States of America Patent
Stats
-
Jul 6, 1993
Issued Date -
N/A
app pub date -
Dec 10, 1990
filing date -
Dec 15, 1988
priority date (Note) -
Expired
status (Latency Note)
Importance
Abstract
A lymphokine is taught which can be used to activate and stimulate CD3.sup.+, CD4.sup.+ T cells, as well as Sezary leukemic T cells. The lymphokine can be obtained from mitogen-stimulated peripheral blood mononuclear cells or urine of Sezary Syndrome patients. The lymphokine upregulates interleukin-2 receptors.
First Claim
Family
International Classification(s)
Cited Art Landscape
Patent Citation Ranking
Advertisement
Advertisement
Advertisement
Recipient Email Address
Recipient Email Address
Comment
Recipient Email Address
Add to Portfolio(s)
To add this patent to one, or more, of your portfolios, simply click the add button.
This Patent is in these Portfolios:
Add to additional portfolios:
Last Refreshed On:
Changes done successfully